Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

16.00USD
20 Apr 2018
Change (% chg)

$0.18 (+1.14%)
Prev Close
$15.82
Open
$15.77
Day's High
$16.34
Day's Low
$15.77
Volume
36,498
Avg. Vol
96,504
52-wk High
$26.74
52-wk Low
$11.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.50 December 23 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.25 1.25 1.25 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 27.17 43.00 18.13 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.50 -0.45 -0.53 --
Quarter Ending Sep-18 3 -0.53 -0.45 -0.61 --
Year Ending Dec-18 3 -2.06 -1.89 -2.19 --
Year Ending Dec-19 4 -2.12 -1.51 -3.00 --
LT Growth Rate (%) 1 -91.20 -91.20 -91.20 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 9.30 0.00 9.30 100.00
Quarter Ending Jun-17 3.10 0.00 3.10 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 5.30 --
Quarter Ending Sep-18 0.00 0.00 0.00 5.85 --
Year Ending Dec-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-19 27.17 31.82 35.00 35.00 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 1 0 1
Earnings